Patents by Inventor Eugene Regis Krah, III

Eugene Regis Krah, III has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DETECTION OF ANTIBODIES TO SARS-COV2
    Publication number: 20230341392
    Abstract: The disclosure is directed to methods and apparatus for the detecting, diagnosis of infection with SARS-CoV-2. The disclosure includes methods for detecting a current or former SARS-CoV-2 infection in an animal, methods for diagnosing and treating an animal infected with SARS-CoV-2. in various aspects, the disclosure is directed to the detection of a nucleocapsid polypeptide of SARS-CoV-2 in a sample from an animal, the detection of a portion of a spike polypeptide of SARS-CoV-2 in a sample from and animal, or detection of both a portion of a spike polypeptide of SARS-CoV-2 and a portion of a nucleocapsid polypeptide of SARS-CoV-2 in a sample from an animal.
    Type: Application
    Filed: June 8, 2021
    Publication date: October 26, 2023
    Inventors: Jesse Stephen Buch, Joshua Michael Boucher, Jiayou Liu, Trevor Justin Morin, Eugene Regis Krah, III
  • Compositions and Methods for Detection of Antibodies Specific for Anaplasma phagocytophilum (Aph) and Anaplasma platys (Apl)
    Publication number: 20150323531
    Abstract: The invention provides methods and compositions for the detection and treatment of Anaplasma phagocytophilum and Anaplasma platys infection.
    Type: Application
    Filed: July 30, 2015
    Publication date: November 12, 2015
    Inventors: Jiayou Liu, Eugene Regis Krah, III, Thomas Patrick O'Connor, JR., Daniel Karl Rieger
  • Compositions and methods for detection of antibodies specific for () and ()
    Patent number: 9120857
    Abstract: The invention provides methods and compositions for the detection and treatment of Anaplasma phagocytophilum and Anaplasma platys infection.
    Type: Grant
    Filed: November 1, 2013
    Date of Patent: September 1, 2015
    Assignee: IDEXX Laboratories, Inc.
    Inventors: Jiayou Liu, Eugene Regis Krah, III, Thomas Patrick O'Connor, Jr., Daniel Karl Rieger
  • DIVA (differentiate infected from vaccinated animals)
    Patent number: 8980274
    Abstract: The invention provides Ehrlichia canis antigens that can be used to detect E. canis infected animals regardless of whether the animals have been vaccinated for E. canis. The invention also provides compositions and methods for determining the presence of E. canis antigens and antibodies.
    Type: Grant
    Filed: January 21, 2011
    Date of Patent: March 17, 2015
    Assignee: IDEXX Laboratories, Inc.
    Inventors: Eugene Regis Krah, III, Melissa Beall, Thomas Patrick O'Connor, Jr., Ramaswamy Chandrashekar
  • DIVA (differentiate infected from vaccinated animals)
    Patent number: 8658387
    Abstract: Ehrlichia canis antigens that can be used to differentiate E. canis infected animals from animals that have been challenged with E. canis, e.g., vaccinated against E. canis, are disclosed. The invention also provides compositions and methods for determining the presence of E. canis antigens and antibodies.
    Type: Grant
    Filed: November 30, 2010
    Date of Patent: February 25, 2014
    Assignee: IDEXX Laboratories, Inc.
    Inventors: Eugene Regis Krah, III, Melissa Beall
  • Compositions and Methods for Detection of Antibodies Specific for Anaplasma phagocytophilum (Aph) and Anaplasma platys (Apl)
    Publication number: 20140050757
    Abstract: The invention provides methods and compositions for the detection and treatment of Anaplasma phagocytophilum and Anaplasma platys infection.
    Type: Application
    Filed: November 1, 2013
    Publication date: February 20, 2014
    Applicant: IDEXX LABORATORIES, INC.
    Inventors: Jiayou Liu, Eugene Regis Krah, III, Thomas Patrick O'Connor, JR., Daniel Karl Rieger
  • Compositions and methods for detection of antibodies specific for (Aph) and (Apl)
    Patent number: 8580272
    Abstract: The invention provides methods and compositions for the detection and treatment of Anaplasma phagocytophilum and Anaplasma platys infection.
    Type: Grant
    Filed: November 5, 2012
    Date of Patent: November 12, 2013
    Assignee: IDEXX Laboratories, Inc.
    Inventors: Jiayou Liu, Eugene Regis Krah, III, Thomas Patrick O'Connor, Jr., Daniel Karl Rieger
  • Methods and compositions for detection of (VLPT)
    Patent number: 8409817
    Abstract: The invention provides methods and compositions for the detection of Ehrlichia chaffeensis.
    Type: Grant
    Filed: June 17, 2011
    Date of Patent: April 2, 2013
    Assignee: IDEXX Laboratories, Inc.
    Inventors: Thomas Patrick O'Connor, Jr., Eugene Regis Krah, III, Jill M. Saucier
  • Compositions and methods for detection of antibodies specific for () and ()
    Patent number: 8303959
    Abstract: The invention provides methods and compositions for the detection and treatment of Anaplasma phagocytophilum and Anaplasma platys infection.
    Type: Grant
    Filed: October 8, 2009
    Date of Patent: November 6, 2012
    Assignee: IDEXX Laboratories, Inc.
    Inventors: Jiayou Liu, Eugene Regis Krah, III, Thomas Patrick O'Connor, Jr., Daniel Karl Rieger
  • Methods and compositions for inhibiting binding of IgE to a high affinity receptor
    Patent number: 8252907
    Abstract: The invention provides methods and compositions for inhibiting binding of IgE to a high affinity receptor. The methods and compositions are useful in the treatment of allergic diseases and allergy symptoms in mammals.
    Type: Grant
    Filed: March 7, 2011
    Date of Patent: August 28, 2012
    Assignee: IDEXX Laboratories, Inc.
    Inventors: Eugene Regis Krah, III, Robert Lawton
  • Feline pancreatic lipase
    Patent number: 8138316
    Abstract: Isolated nucleic acid molecules having a nucleotide sequence encoding feline pancreatic lipase polypeptides, splice variants, allelic variants, and fragments thereof. Isolated feline pancreatic lipase polypeptides, splice variants, allelic variants, and fragments thereof. Host cells comprising a vector containing the polynucleotide sequences and methods for expressing the polypeptides. The generation of monoclonal antibodies that specifically binds to the feline pancreatic lipase polypeptides, and cell lines secreting the monoclonal antibodies. Methods for determining the presence or amount of feline pancreatic lipase in a biological sample. The methods include using standards or calibrators of recombinant feline pancreatic lipase to quantify the lipase in a sample. Devices and kits for performing methods for detecting feline pancreatic lipase in biological samples.
    Type: Grant
    Filed: June 10, 2010
    Date of Patent: March 20, 2012
    Assignee: IDEXX Laboratories, Inc.
    Inventors: Philip Andersen, Melissa Jane Beall, Jesse Buch, Ku-chuan Hsiao, Stacey Pazar Huth, Eugene Regis Krah, III, Barbara O'Brien, Marilyn Strong-Townsend
  • Methods and Compositions for Detection of Ehrlichia chaffeensis (VLPT)
    Publication number: 20110250615
    Abstract: The invention provides methods and compositions for the detection of Ehrlichia chaffeensis.
    Type: Application
    Filed: June 17, 2011
    Publication date: October 13, 2011
    Inventors: Thomas Patrick O'Connor, JR., Jill M. Saucier, Eugene Regis Krah, III
  • Ehrlichia canis DIVA (Differentiate Infected from Vaccinated Animals)
    Publication number: 20110182925
    Abstract: The invention provides Ehrlichia canis antigens that can be used to detect E. canis infected animals regardless of whether the animals have been vaccinated for E. canis. The invention also provides compositions and methods for determining the presence of E. canis antigens and antibodies.
    Type: Application
    Filed: January 21, 2011
    Publication date: July 28, 2011
    Inventors: Eugene Regis Krah III, Melissa Beall, Thomas Patrick O'Connor, JR., Ramaswamy Chandrashekar
  • Methods and Compositions for Inhibiting Binding of IgE to a High Affinity Receptor
    Publication number: 20110158981
    Abstract: The invention provides methods and compositions for inhibiting binding of IgE to a high affinity receptor. The methods and compositions are useful in the treatment of allergic diseases and allergy symptoms in mammals.
    Type: Application
    Filed: March 7, 2011
    Publication date: June 30, 2011
    Inventors: Eugene Regis Krah, III, Robert Lawton
  • Methods and compositions for detection of (VLPT)
    Patent number: 7964366
    Abstract: The invention provides methods and compositions for the detection of Ehrlichia chaffeensis.
    Type: Grant
    Filed: September 19, 2008
    Date of Patent: June 21, 2011
    Assignee: IDEXX Laboratories, Inc.
    Inventors: Thomas Patrick O'Connor, Jr., Eugene Regis Krah, III, Jill M. Saucier
  • Methods and compositions for inhibiting binding of IgE to a high affinity receptor
    Patent number: 7931898
    Abstract: The invention provides methods and compositions for inhibiting binding of IgE to a high affinity receptor. The methods and compositions are useful in the treatment of allergic diseases and allergy symptoms in mammals.
    Type: Grant
    Filed: May 9, 2008
    Date of Patent: April 26, 2011
    Assignee: IDEXX Laboratories, Inc.
    Inventors: Eugene Regis Krah, III, Robert Lawton
  • Ehrlichia canis DIVA (Differentiate Infected from Vaccinated Animals)
    Publication number: 20110091995
    Abstract: Ehrlichia canis antigens that can be used to differentiate E. canis infected animals from animals that have been challenged with E. canis, e.g., vaccinated against E. canis, are disclosed. The invention also provides compositions and methods for determining the presence of E. canis antigens and antibodies.
    Type: Application
    Filed: November 30, 2010
    Publication date: April 21, 2011
    Inventors: EUGENE REGIS KRAH, III, MELISSA BEALL
  • DIVA (differentiate infected from vaccinated animals)
    Patent number: 7888054
    Abstract: The invention provides Ehrlichia canis antigens that can be used to detect E. canis infected animals regardless of whether the animals have been vaccinated for E. canis. The invention also provides compositions and methods for determining the presence of E. canis antigens and antibodies.
    Type: Grant
    Filed: October 31, 2008
    Date of Patent: February 15, 2011
    Assignee: IDEXX Laboratories, Inc.
    Inventors: Eugene Regis Krah, III, Melissa Beall, Thomas Patrick O'Connor, Jr., Ramaswamy Chandrashekar
  • DIVA (differentiate infected from vaccinated animals)
    Patent number: 7842473
    Abstract: Ehrlichia canis antigens that can be used to differentiate E. canis infected animals from animals that have been challenged with E. canis, e.g., vaccinated against E. canis, are disclosed. The invention also provides compositions and methods for determining the presence of E. canis antigens and antibodies.
    Type: Grant
    Filed: April 4, 2006
    Date of Patent: November 30, 2010
    Assignee: IDEXX Laboratories, Inc.
    Inventors: Eugene Regis Krah, III, Melissa Beall
  • DIVA (differentiate infected from vaccinated animals)
    Patent number: 7842474
    Abstract: Ehrlichia canis antigens that can be used to differentiate E. canis infected animals from animals that have been challenged with E. canis, e.g., vaccinated against E. canis, are disclosed. The invention also provides compositions and methods for determining the presence of E. canis antigens and antibodies.
    Type: Grant
    Filed: October 4, 2006
    Date of Patent: November 30, 2010
    Assignee: IDEXX Laboratories, Inc.
    Inventors: Eugene Regis Krah, III, Thomas Patrick O'Connor, Jr., Melissa Beall